文献速递生殖医学

卵巢组织冷冻移植成功率的决定因素:FertiPROTEKT网络196例女性数据

Determinants of transplantation success with cryopreserved ovarian tissue: data from 196 women of the FertiPROTEKT network.
PubMed 文献 · Hum Reprod · 2022-01-01

基于FertiPROTEKT网络26个中心2007至2019年登记的196例女性244次卵巢组织移植,分析妊娠率、活产率及相关因素。每例患者妊娠率32.7%、活产率26.5%,成功率与冷冻时女性年龄及首次与重复移植相关。

要点

  • 每例患者妊娠率32.7%(95%CI 26.1-39.7%),活产率26.5%(95%CI 20.5-33.3%)。
  • 首次移植妊娠率30.6%高于第二次及后续移植的11.8%。
  • 冷冻时年龄<35岁者活产率28.2%,>35岁者16.7%。

核心结论

  • 卵巢组织冷冻移植妊娠率与活产率分别为每例患者32.7%和26.5%,成功率与女性年龄及首次与重复移植相关。

研究设计与样本

  • FertiPROTEKT网络登记分析,26个中心2007至2019年共196例女性244次移植,随访至2020年12月。
  • 196例中191例既往恶性肿瘤、5例既往非恶性疾病;移植中心规模为每中心1至100次移植(中位数2次)。

主要发现

  • 196例女性冷冻时平均年龄31.3岁(SD 5.2;范围17-44),移植时平均年龄35.9岁(SD 4.8;范围23-47)。
  • 首次移植妊娠率30.6%(95%CI 24.2-37.6%),每例患者妊娠率32.7%(95%CI 26.1-39.7%)。
  • 首次移植活产率25.0%(95%CI 19.1-31.7%),每例患者活产率26.5%(95%CI 20.5-33.3%)。
  • 首次移植妊娠率30.6%(95%CI 24.2-37.6%)高于第二次及后续移植的11.8%(95%CI 3.3-27.5%)。
  • 冷冻时年龄<35岁者活产率28.2%(95%CI 20.9-36.3%),>35岁者16.7%(95%CI 7.9-29.3%)。

临床怎么用

  • 作者认为卵巢组织冷冻移植潜力高,但仅在较年轻女性中冷冻时才能体现。
  • 作者建议关注首次移植而非重复移植,并提出是否应由有经验的中心实施移植的讨论。

局限性

  • 数据来自登记分析。
  • 卵巢储备和早发性卵巢功能不全等数据并非所有女性均有。
  • 数据可能受各中心不同随访策略影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What are the pregnancy and live birth rates for ovarian tissue transplantation and which factors are associated with the success rate? SUMMARY ANSWER: Pregnancy and live birth rates per transplanted woman are 32.7% and 26.5% and success rate is associated with female age and first versus repeated transplantation. WHAT IS KNOWN ALREADY: Live birth rates after ovarian tissue transplantations have been reported to be between around 24% and 41% per patient. Success rates seem to be negatively associated with increasing female age at the time of tissue cryopreservation and with pelvic radiation. Success rates are apparently not reduced after overnight transportation of ovarian tissue before freezing. STUDY DESIGN, SIZE, DURATION: Registry analysis of 244 transplantations in 196 women, performed by 26 FertiPROTEKT network centres from 2007 to 2019 with follow-up till December 2020. PARTICIPANTS/MATERIALS, SETTING, METHODS: Orthotopic ovarian tissue transplantations were performed in 196 women, 191 with previous malignant and 5 with previous non-malignant diseases. Size of transplanting centres varied between 1 and 100 transplantations per centre (median: 2). Factors possibly associated with success rate such as female age, first and repeated transplantation, experience of the transplanting centre and overnight transportation of the ovarian tissue before freezing were analysed. MAIN RESULTS AND THE ROLE OF CHANCE: Average age of all 196 transplanted women was 31.3 years (SD 5.2; range 17-44) at the time of cryopreservation of tissue and 35.9 years (SD 4.8; range 23-47) at the time of transplantation. Pregnancy rate was 30.6% (95% CI, 24.2-37.6%) per first transplantation and 32.7% (95% CI, 26.1-39.7%) per patient. Pregnancy rate was higher after first transplantation (30.6% (95% CI, 24.2-37.6%)) compared to second and subsequent transplantations (11.8% (95% CI, 3.3-27.5%)). Live birth rate per first transplantation was 25.0% (95% CI, 19.1-31.7%) and per patient 26.5% (95% CI, 20.5-33.3%). Success rate decreased with increasing age at the time of ovarian tissue freezing. Live birth rate was 28.2% (95% CI, 20.9-36.3%) in women <35 years and 16.7% (95% CI, 7.9-29.3%) in women >35 years. Pregnancy rates after first transplantation were higher in centres who had performed ≥10 transplantations (35.1%) compared to centres with <10 transplantation (25.4%) (P = 0.12). Corresponding live birth rates were 27.0% and 18.6%. Success rates were not different in women with and without overnight transportation of tissue before cryopreservation. LIMITATIONS, REASONS FOR CAUTION: The data were drawn from a registry analysis. Data such as ovarian reserve and premature ovarian insufficiency were not available for all women. Data might be influenced by different follow-up policies of the centres. WIDER IMPLICATIONS OF THE FINDINGS: The study reveals the high potential of ovarian tissue freezing and transplantation, but only if freezing is performed in younger women. The study suggests focus should be placed on the first and not on repeated transplantations. It also opens the discussion of whether transplantation should rather be performed by experienced centres. STUDY FUNDING/COMPETING INTEREST(S): No funding. No competing interests. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Lotz L, Bender-Liebenthron J, Dittrich R, et al. Determinants of transplantation success with cryopreserved ovarian tissue: data from 196 women of the FertiPROTEKT network. Hum Reprod. 2022. PMID: 36272106. doi:10.1093/humrep/deac225

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。